Dr Kneeland Youngblood - Jun 7, 2023 Form 4 Insider Report for Light & Wonder, Inc. (LNW)

Role
Director
Signature
/s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood
Stock symbol
LNW
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 05:22 PM
Previous filing
Jun 21, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LNW Common Stock Options Exercise $0 +3.84K +30.16% $0.00 16.6K Jun 8, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNW Restricted Stock Units Award $0 +3.32K $0.00 3.32K Jun 7, 2023 Common Stock 3.32K Direct F1
transaction LNW Restricted Stock Units Options Exercise $0 -3.84K -100% $0.00* 0 Jun 8, 2023 Common Stock 3.84K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units are scheduled to vest on June 7, 2024. Each unit converts into a share of common stock on a one-for-one basis.
F2 Represents vesting of restricted stock units granted on June 8, 2022. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.